Based on data from the past 90 days ending December 12, 2025, Heron Therapeutics's three largest insider shareholders are TenPercentOwner Capital Management Lp Rubric (30.05Mn shares), Chief Executive Officer Craig A Collard (523.12K shares), EVP And Chief Financial Officer Ira Duarte (179.79K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Capital Management Lp Rubric | 30,046,828 | 17 Oct, 2025 | |
| Adam Morgan | 8,823,067 | 04 Feb, 2025 | |
| Craig A Collard | Chief Executive Officer | 523,124 | 04 Nov, 2025 |
| Ira Duarte | EVP And Chief Financial Officer | 179,786 | 04 Nov, 2025 |
| Barry D Quart | Chief Executive Officer | 177,989 | 17 Jan, 2023 |
| William P Forbes | EVP And Chief Development Officer | 166,203 | 04 Nov, 2025 |
| Susan Rodriguez | 87,180 | 04 Feb, 2025 | |
| Sharmila Dissanaike | 87,180 | 04 Feb, 2025 | |
| Waage Christian | 84,130 | 04 Feb, 2025 | |
| Craig A Johnson | 83,770 | 04 Feb, 2025 | |
| Lisa Peraza | VP And Chief Accounting Officer | 55,907 | 16 Jan, 2024 |
| Michael Kaseta | 55,829 | 04 Feb, 2025 | |
| Stephen Davis | 52,032 | 20 Dec, 2022 | |
| John Poyhonen | President & Cco | 46,648 | 17 Apr, 2023 |
| Thomas Cusack | 37,879 | 12 Nov, 2025 | |
| David Leslie Szekeres | EVP And Chief Operating Officer | 33,754 | 17 Jul, 2023 |
| Kimberly Manhard | EVP And Drug Development | 28,330 | 17 Apr, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 08 Nov, 2025 | Thomas Cusack | Common Stock | A | 37,879 | - | 37,879 | D | A |
| 31 Oct, 2025 | Craig A Collard | Common Stock | A | 34,789 | - | 523,124 | D | M |
| 31 Oct, 2025 | Ira Duarte | Common Stock | A | 11,694 | - | 179,786 | D | M |
| 31 Oct, 2025 | William P Forbes | Common Stock | A | 11,694 | - | 166,203 | D | M |
| 19 Oct, 2025 | Ira Duarte | Common Stock | A | 3,874 | - | 168,092 | D | M |
| 19 Oct, 2025 | William P Forbes | Common Stock | A | 3,874 | - | 154,509 | D | M |
| 19 Oct, 2025 | Craig A Collard | Common Stock | A | 13,797 | - | 488,335 | D | M |
| 15 Oct, 2025 | Capital Management Lp Rubric | Common Stock, par value $0.01 per share ("Common Stock") | A | 946,100 | - | 30,046,828 | I | C |
| 08 Aug, 2025 | Adam Morgan | - | - | 8,753,290 | I | |||
| 08 Aug, 2025 | Adam Morgan | Common Stock | A | 1,766,546 | $1.50 | 8,753,290 | I | P |
| 08 Aug, 2025 | Capital Management Lp Rubric | Common Stock, par value $0.01 per share ("Common Stock") | A | 2,387,225 | $1.50 | 29,100,728 | I | P |
| 31 Jul, 2025 | William P Forbes | Common Stock | A | 11,695 | - | 150,635 | D | M |
| 31 Jul, 2025 | Craig A Collard | Common Stock | A | 34,789 | - | 474,538 | D | M |
| 19 Jul, 2025 | William P Forbes | Common Stock | A | 3,874 | - | 138,940 | D | M |
| 31 Jul, 2025 | Ira Duarte | Common Stock | A | 11,695 | - | 164,218 | D | M |
| 19 Jul, 2025 | Ira Duarte | Common Stock | A | 3,874 | - | 152,523 | D | M |
| 19 Jul, 2025 | Craig A Collard | Common Stock | A | 13,797 | - | 439,749 | D | M |
| 16 Jun, 2025 | Ira Duarte | Common Stock | A | 12,500 | - | 148,649 | D | M |
| 06 Jun, 2025 | William P Forbes | Common Stock | A | 12,500 | - | 135,066 | D | M |
| 30 Apr, 2025 | Ira Duarte | Common Stock | A | 11,694 | - | 136,149 | D | M |